0001567619-20-019261.txt : 20201112 0001567619-20-019261.hdr.sgml : 20201112 20201112134150 ACCESSION NUMBER: 0001567619-20-019261 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20201112 FILED AS OF DATE: 20201112 DATE AS OF CHANGE: 20201112 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cutler Adam D. CENTRAL INDEX KEY: 0001722673 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39685 FILM NUMBER: 201305527 MAIL ADDRESS: STREET 1: 9301 AMBERGLEN BOULEVARD, SUITE 100 STREET 2: C/O MOLECULAR TEMPLATES, INC. CITY: AUSTIN STATE: TX ZIP: 78729 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: InMed Pharmaceuticals Inc. CENTRAL INDEX KEY: 0001728328 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: SUITE 310, 815 W. HASTINGS STREET CITY: VANCOUVER STATE: A1 ZIP: V6C 1B4 BUSINESS PHONE: (604) 669-7207 MAIL ADDRESS: STREET 1: SUITE 310, 815 W. HASTINGS STREET CITY: VANCOUVER STATE: A1 ZIP: V6C 1B4 3 1 doc1.xml FORM 3 X0206 3 2020-11-12 0 0001728328 InMed Pharmaceuticals Inc. INM 0001722673 Cutler Adam D. C/O INMED PHARMACEUTICALS INC. SUITE 310 - 815 HASTINGS STREET VANCOUVER A1 V6C 1B4 BRITISH COLUMBIA, CANADA 1 0 0 0 Director Stock Option (Right to Buy) 3.54 2015-11-27 2020-11-27 Common Shares 1515 D Director Stock Option (Right to Buy) 2.78 2016-07-26 2021-07-26 Common Shares 22727 D Director Stock Option (Right to Buy) 12.65 2019-01-14 2024-01-14 Common Shares 1061 D Director Stock Option (Right to Buy) 6.33 2025-01-11 Common Shares 1061 D Director Stock Option (Right to Buy) 3.67 2015-11-23 2020-11-23 Common Shares 6061 D Converted from the Canadian exercise price of $4.62 using an exchange rate of C$1.3039 = US$1.00. Converted from the Canadian exercise price of C$3.63 using an exchange rate of C$1.3039 = US$1.00. Converted from the Canadian exercise price of C$16.50 using an exchange rate of C$1.3039 = US$1.00. Converted from the Canadian exercise price of C$8.25 using an exchange rate of C$1.3039 = US$1.00. Converted from the Canadian exercise price of C$4.79 using an exchange rate of C$1.3039 = US$1.00. The options were granted on January 12, 2020, and will fully vest on the earlier of January 12, 2021, or immediately prior to the Issuer's next annual general meeting. Exhibit 24.1 Power of Attorney /s/ Adam D. Cutler 2020-11-12 EX-24.1 2 poa.htm POWER OF ATTORNEY POWER OF ATTORNEY 
POWER OF ATTORNEY
Know all by these presents, that the undersigned hereby constitutes and appoints Bruce S. Colwill and
Rocio Lebolo, each acting alone, as the undersigned's true and lawful attorney-in-fact to:
(1)	execute for and on behalf of the undersigned, in the undersigned's capacity as an officer,
director and/or 10% shareholder of InMed Pharmaceuticals Inc. (the "Company"), Forms 3, 4 and 5
(including amendments thereto) in accordance with Section 16(a) of the Securities Exchange Act of 1934
and the rules and regulations thereunder and any Form ID, Uniform Application for Access Codes to File
on Edgar, or Update Passphrase Form;
(2)	do and perform any and all acts for and on behalf of the undersigned which may be necessary or
desirable to complete and execute any such Forms 3, 4 or 5, Form ID or Update Passphrase Form and timely
file such forms (including amendments thereto) and application with the United States Securities and
Exchange Commission and any stock exchange or similar authority; and
(3) 	take any other action of any type whatsoever in connection with the foregoing which, in the
opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required
by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf
of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms
and conditions as such attorney-in-fact may approve in such attorney-in-fact's discretion.
The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform
any and every act and thing whatsoever requisite, necessary or proper to be done in the exercise of any
of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might
or could do if personally present, with full power of substitution or revocation, hereby ratifying and
confirming all that such attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall
lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein
granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity
at the request of the undersigned, are not assuming, nor is the Company assuming, any of the
undersigned's responsibilities to comply with Section 16 of the Securities Exchange Act of 1934.
The undersigned agrees that each such attorney-in-fact herein may rely entirely on information furnished
orally or in writing by the undersigned to such attorney-in-fact. The undersigned also agrees to
indemnify and hold harmless the Company and each such attorney-in-fact against any losses, claims,
damages or liabilities (or actions in these respects) that arise out of or are based upon any untrue
statements or omission of necessary facts in the information provided by the undersigned to such
attorney-in fact for purposes of executing, acknowledging, delivering or filing Forms 3, 4 or 5 (including
amendments thereto), Form ID or Update Passphrase Form and agrees to reimburse the Company and such
attorney-in-fact for any legal or other expenses reasonably incurred in connection with investigating
or defending against any such loss, claim, damage, liability or action.
This Power of Attorney supersedes any power of attorney previously executed by the undersigned regarding
the purposes outlined in the first paragraph hereof ("Prior Powers of Attorney"), and the authority of
the attorneys-in-fact named in any Prior Powers of Attorney is hereby revoked.
This Power of Attorney shall remain in full force and effect until the undersigned is no longer required
to file Forms 3, 4 or 5 with respect to the undersigned's holdings of and transactions in securities
issued by the Company, unless earlier (a) revoked by the undersigned in a signed writing delivered to
the foregoing attorneys-in-fact or (b) superseded by a new power of attorney regarding the purposes
outlined in the first paragraph hereof dated as of a later date.
IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 10th day
of November, 2020.

/s/ Adam D. Cutler
ADAM D. CUTLER